Maurizio Baldassarini
Director/Board Member bei TAKE OFF S.P.A.
Profil
Maurizio Baldassarini is a founding partner of BOCG Associati since 2005.
He is currently an independent director at VNE SpA, a director at Fenix Entertainment SpA, an independent director at Take Off SpA, and a founding partner at EQValue Srl since 2008.
He was previously an independent non-executive director at Cassiopea SpA from 2018 to 2022 and a professor at Sapienza University of Rome.
He obtained an undergraduate degree from Sapienza University of Rome.
Aktive Positionen von Maurizio Baldassarini
Unternehmen | Position | Beginn |
---|---|---|
TAKE OFF S.P.A. | Director/Board Member | - |
FENIX ENTERTAINMENT S.P.A. | Director/Board Member | - |
VNE S.P.A. | Director/Board Member | - |
BOCG Associati
BOCG Associati Investment ManagersFinance BOCG Associati provides investment advice. The private company is based in Rome, Italy. The Italian company was founded by Maurizio Baldassarini, Roger Olivieri. | Founder | 01.01.2005 |
EQValue Srl | Private Equity Investor | 01.01.2008 |
Ehemalige bekannte Positionen von Maurizio Baldassarini
Unternehmen | Position | Ende |
---|---|---|
CASSIOPEA S.P.A. | Director/Board Member | 01.01.2022 |
Sapienza University of Rome | Corporate Officer/Principal | - |
Ausbildung von Maurizio Baldassarini
Sapienza University of Rome | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
VNE S.P.A. | Producer Manufacturing |
FENIX ENTERTAINMENT S.P.A. | Consumer Services |
TAKE OFF S.P.A. | Retail Trade |
Private Unternehmen | 3 |
---|---|
Cassiopea SpA
Cassiopea SpA Pharmaceuticals: MajorHealth Technology Cassiopea SpA is a clinical-stage specialty pharmaceutical company. It engages in developing and commercializing medical dermatology products focusing on the topical treatment of acne, androgenic alopecia, and genital warts. The firm's products include Winlevi, Breezula, Clascoterone Solution, CB-06-02, and CB-06-01. The company was founded on July 30, 2013 and is headquartered in Milan, Italy. | Health Technology |
EQValue Srl | |
BOCG Associati
BOCG Associati Investment ManagersFinance BOCG Associati provides investment advice. The private company is based in Rome, Italy. The Italian company was founded by Maurizio Baldassarini, Roger Olivieri. | Finance |